Tempest Therapeutics (TPST) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.57
-0.49
-0.42
-0.34

Details

Expected EPS
-0.40255
Actual EPS
-0.36
Surprise EPS
0.04
Surprise Percent
+10.57%

Description

Tempest Therapeutics (TPST) has reported earnings of -0.36 per share for Q2 2024.

0 Comments

Share your thoughts